Corcept Therapeutics | CORT - Current Liabilities

Stock Price
46.06
Daily Change
0.98 2.17%
Monthly
13.81%
Yearly
-35.77%
Q2 Forecast
45.07

Corcept Therapeutics reported $166.08M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Acadia Pharmaceuticals USD 277.11M 79.47M Dec/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
ANI Pharmaceuticals USD 278.11M 7.56M Dec/2025
Ardelyx USD 88.6M 5.22M Dec/2025
Assertio Holdings USD 166.78M 34.25M Sep/2025
Aurora Cannabis CAD 145.94M 21.82M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Canopy Growth CAD 98.29M 17.19M Dec/2025
Corcept Therapeutics USD 166.08M 6.18M Dec/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Esperion Therapeutics USD 300.81M 58.22M Dec/2025
J&J USD 57.72B 3.59B Mar/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Lexicon Pharmaceuticals USD 20.87M 853K Dec/2025
Merck USD 28.63B 2.59B Sep/2025
Nektar Therapeutics USD 53.54M 12.8M Dec/2025
Novartis USD 27.28B 4.72B Dec/2025
Novartis USD 27.28B 4.72B Dec/2025
Omeros USD 85.5M 2.28M Jun/2025
Pacira USD 120.59M 13.51M Dec/2025
Pfizer USD 36.6B 1.13B Sep/2025
Supernus Pharmaceuticals USD 338.17M 7.54M Dec/2025
TG Therapeutics USD 153.76M 3.05M Dec/2025